•  
  •  
  •  
  •  

2026-07-25 04:15:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
  • New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
  • NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
  • Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
  • Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%

Keywords Selected:  3Observations

Stock Report

  • USFDA inspection at Somerset facility of Lupin Ltd
  • Apitoria Pharma Pvt Ltd receives 3 observations from USFDA for Unit-V
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Senores Pharmaceuticals Ltd's material subsidiary reeceives 3 observations from USFDA for its facility
  • Lupin receives Form 483 with 3 observations from USFDA for Pithampur Unit-3
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
  • Eugia Steriles Pvt Ltd gets 3 observations from USFDA for Injectable Facility
  • Dr. Reddy's Laboratories Ltd gets 3 observations from USFDA for R&D Centre
  • Alkem Laboratories Ltd receives 3 observations from USFDA for API manufacturing facility located at Mandva
  • Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village
  • Neuland Laboratories Limited updates on USFDA inspection
  • Hikal announces US FDA Audit with Zero Observations
  • Ipca Laboratories Limited gets 3 observations for Piparia, Silvassa unit
  • Zydus Lifesciences Ltd gets 3 observations from USFDA for Pharmex, Ahmedabad facility
  • Granules India Ltd gets 3 observations from USFDA for Gagillapur facility
  • Strides announces successful completion of US FDA inspection at its Singapore facility
  • USFDA issues 3 observations for Aurobindo Pharma Ltd's Unit XI
  • Biocon gets 3 observations from US FDA for Site 3 at Hyderabad
  • US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA

Latest Post

  • TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
  • New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
  • NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
  • Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
  • Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025